Literature DB >> 16411197

Temporary diabetes mellitus secondary to a primary pancreatic Burkitt lymphoma.

Constance Meier1, Thomas Kapellen, Ralph B Tröbs, Wolfgang Hirsch, Reto Parwaresch, Wieland Kiess, Dieter Körholz.   

Abstract

Primary pancreatic lymphoma (PPL) is a rare form of extranodal lymphoma. So far, only in adults has a coincidence with diabetes mellitus (DM) been described. We report a nearly 9-year-old German boy presenting with a Burkitt lymphoma associated with a temporary insulin-dependent DM and exocrine insufficiency of the pancreas. After the patient went into remission, a spontaneous recovery of the endocrine pancreatic function was observed. On immunophenotyping, the lymphoma cells revealed expression of FasL suggesting a potentially apoptotic effect on pancreatic tissue. Beta cell impairment may have been caused by FasL resembling autoimmune diabetes. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16411197     DOI: 10.1002/pbc.20752

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  [Pancreatitis as the initial manifestation and abdominal lymph node enlargement in a boy].

Authors:  You-Hong Fang; Ke-Rong Peng; Fei-Bo Chen; Lu-Jing Tang; Jie Chen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-10

Review 2.  Primary Pancreatic Lymphoma: Recommendations for Diagnosis and Management.

Authors:  Davide Facchinelli; Enrico Boninsegna; Carlo Visco; Cristina Tecchio
Journal:  J Blood Med       Date:  2021-05-05

3.  Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3.

Authors:  Valentina Bozzoli; Maria Chiara Tisi; Luigi Pianese; Stefano Tumini; Vittoria Rufini; Maria Lucia Calcagni; Dario Pitocco; Alberto Larghi; Luigi Maria Larocca; Giuseppina Massini; Luciana Teofili; Francesco D'Alò; Stefan Hohaus
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-01-18       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.